1[1]Julius S,Kjeldsen SE,Weber M,et al.Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial[J].Lancet,2004,363:2022-2031.
2[2]Messerli FH,Staessen JA.Amlodipine better than lisinopril? How one randomized clinical trial ended fallacies from observational studies[J].Hypertension,2006,48:359-361.
3[3]Poole-Wilson PA,Lubsen J,Kirwan BA,et al.Effect of longacting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):randomised controlled trial[J].Lancet,2004,364:849-857.
4[4]The DREAM Trial Investigators.Effect of ramipril on the incidence of diabetes[J].N Engl J Med,2006,355.
5[5]Jan A,Staess EN,Yan LI,et al.Blood pressure reduction and cardiovascular prevention:An update including the 2003-2004 Secondary prevention trials[J].Hypertens Res,2005,28:385-407.
6[6]Blood pressure lowering treatment trialists' collaboration..effects of different blood-pressure-lowering regimens on major cardiovascular events:results of prospectively designed overviews of randomised trials[J].Lancet,2003,362:1527-1535.
